![Paul Lizzul](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Lizzul
Plus aucun poste en cours
Fortune : 4 M $ au 31/08/2026
Profil
Paul F.
Lizzul is currently a Member at the American Academy of Dermatology and Chief Medical Officer at First Tracks Biotherapeutics, Inc. Former positions include Executive Medical Director at Amgen, Inc. in 2020, Senior Medical Director & Head-Safety at Kythera Biopharmaceuticals LLC from 2012 to 2016, Assistant Professor at Tufts University School of Medicine from 2009 to 2012, Chief Medical Officer at Sienna Biopharmaceuticals, Inc., and Chief Medical Officer at AnaptysBio, Inc. from 2020 to 2026.
Education includes a doctorate from the University of Medicine & Dentistry of New Jersey, an undergraduate degree from Rensselaer Polytechnic Institute, a graduate degree from Robert Wood Johnson Medical School, and an MBA from Rutgers Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANAPTYSBIO, INC. 0,14 % | 01/06/2026 | 42 669 ( 0,14 % ) | 2 M $ | 31/08/2026 |
0,12 % | 15/08/2026 | 42 669 ( 0,12 % ) | 2 M $ | 31/08/2026 |
Postes actifs de Paul Lizzul
| Sociétés | Poste | Début |
|---|---|---|
American Academy of Dermatology
 American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services Operates as dermatologists organizations | Corporate Officer/Principal | - |
Anciens postes connus de Paul Lizzul
| Sociétés | Poste | Fin |
|---|---|---|
| ANAPTYSBIO, INC. | Directeur Technique/Scientifique/R&D | 20/04/2026 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/07/2020 |
| KYTHERA BIOPHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 01/01/2016 |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2012 |
| SIENNA BIOPHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Paul Lizzul
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes novel dermatology prescription drugs | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
 Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Dermatology
American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services Operates as dermatologists organizations | Commercial Services |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
